Infectious Disease and Vaccines

Tackle even the most complex trials with integrated expertise

We develop comprehensive strategies for treating and preventing life-threatening illnesses, no matter how complex. How? By integrating our deep scientific, epidemiological, medical, public health, and regulatory expertise with solutions that cover everything from medical feasibility assessment to trial management, pathogen surveillance, and market access.


Lean on our holistic, cross-functional team

Our infectious disease team is built upon the global experience and public health knowledge your project needs. Our expertise includes regulatory affairs, real-world evidence, epidemiology, genomics, pulmonology, cardiology, and all other relevant therapeutic areas across age groups. With this expertise, we optimize protocols and implement innovative trial designs to drive your research forward.

Experience in the past 5 years with infectious disease & vaccines

clinical projects
enrolled patients

Viral indications

Our team has extensive global experience with viral indications that include COVID-19, SARS, H1N1, MERS, and Ebola, as well as influenza, RSV, HIV/AIDS, HSV, HPV, and hepatitis B and C.

Bacterial indications

We have specialized expertise in multi-drug-resistant infections, including cIA, cUTI, HAP/VAP, ABSSI, joint infections, and osteomyelitis.

Vaccines, preventative, and treatment

We’ve done extensive work in preventing and treating COVID-19, influenza, RSV, pneumococcal and meningococcal infections, and dengue, including development experience with pandemic vaccines and with combination vaccines for pediatrics.

Critical care

We offer access to a global network of critical care specialty centers, with particular expertise in sepsis indications, nosocomial infections, and hospital-based critical care studies.

Long COVID syndrome

We’ve developed a Long COVID Syndrome Program to address the continuing impact on these patients — working with sites, registries, and patients across therapeutic areas to streamline research. For these patients and their little-understood conditions, it’s more crucial than ever to listen to their voices, seating them at the head of the table to guide us toward meaningful outcomes. We also bring strong experience working on COVID-19 treatments, with recognition as a top-ranked CRO for COVID-19 clinical development services, according to the Life Science Strategy Group.


Strong focus on vaccines

Our extensive vaccine experiences and capabilities help your trials thrive throughout the life of your program. We’ve developed regional pathogen surveillance programs, conducted global epidemiology research, and are involved in ongoing regional incidence tracking. We also use patient mapping, chart reviews, community outreach, and lab results to target future volunteers at their first point of medical contact. 

Better access to diverse patient segments

We’ve developed methods for recruiting study participants ranging from neonates to geriatrics, with a global network of research sites that include vaccine centers, decentralized community outreach, outpatient clinics, hospitals, and critical-care specialty centers. This ensures you have access to the patients you need.

End-to-end support, whatever you need

Our cross-functional expertise is integrated across all stages of development, from Phase I to Phase IV. Our deep understanding of the nuances of delivering trials for infectious disease is reflected in our operational excellence, which includes a specific focus on microbiological and clinical endpoints, as well as long-term surveillance and case event capture.

Deep experience with academic and government research

In addition to lab-based work that incorporates genomics, prognostic biomarkers, and state-of-the-art diagnostics, we bring extensive expertise in hospital-based and global trials for academic research, as well as research funded by third-party organizations like governments (BARDA, NIH, EMA) and grant providers.


Therapeutic insights

See our latest insights for infectious disease & vaccines

Want to hear from our experts on the latest topics in infectious disease and vaccines? Visit our Insights Center to read, watch, and listen.

See insights